<DOC>
	<DOCNO>NCT00519155</DOCNO>
	<brief_summary>The purpose study gain experience safety efficacy MD05 man alveolar bone regeneration .</brief_summary>
	<brief_title>Pilot Study MD05 Comparison With Open Flap Debridement Patients Undergoing Periodontal Surgery</brief_title>
	<detailed_description />
	<mesh_term>Alveolar Bone Loss</mesh_term>
	<criteria>Patients require extraction teeth advance intrabony periodontal defect single root teeth without root concavities/furrows locate maxilla mandible ( maxillary/mandibular premolar , maxillary incisor ; presurgery probe depth ≥ 6 mm , intrasurgery defect depth ≥ 4 mm ) locate mesial distal aspect mandibular molar teeth without adjacent teeth ( exclude defect also involve furcation area ) . Teeth treat must schedule extraction treatment plan establish clinician unrelated study . Male female patient , age 18 75 year Patients must nonsmoker Female patient must infertile ( either sterilize postmenopausal ) . If patient 's menopausal status screen uncertain , level follicle stimulate hormone ( FSH ) determine . Patients FSH level &gt; 25 IU/l absence menstrual bleeding &gt; 6 month satisfy definition postmenopausal status . Patient must provide write informed consent Women childbearing potential , pregnant lactate woman Participation another clinical study within 30 day prior study start Previous participation study Legal incompetence restrict legal competence Alcoholism , drug dependency , smoke Acute chronic infection application site Known infection HIV , HBV , HCV Severe allergic rhinitis require permanent medication Known intolerance hypersensitivity ßTCP rhGDF ? 5 Presence local systemic malignant disease history local systemic malignant disease past 5 year . Patients require chemo radiotherapy Previous current radiotherapy head Chronic liver disorder ( AST and/or ALT 2 time upper limit normal ) Impaired renal function ( creatinine 1.5 time upper limit normal ) Uncontrolled insulindependent diabetes mellitus ( HbA1c &gt; 7 % ) Clinically relevant symptom thyroid dysfunction Severe hypertension ( RRdiast &gt; 110 mmHg ) Clinically relevant cardiovascular disease e.g. , decompensated cardiac insufficiency , hemodynamically relevant heart valve defect , myocardial infarction last three month Systemic bone disease illness influence bone metabolism ( e.g . Osteogenesis imperfecta , Paget 's disease , EhlersDanlos disease , osteomalacia , renal osteodystrophia , hyperparathyroidism ) Clinically relevant blood coagulation disorder Leukopenia &lt; 3.500 leukocytes/µL Previous ( within last 2 month screen visit ) current treatment systemic corticosteroid 5 mg/day prednisone equivalent Previous current therapy drug influence bone metabolism calcitonin parathormone ( teriparatid ) within last 6 month screen visit , bisphosphonates fluoride least 30 day within last 12 month screen visit Previous ( within last 2 month screen visit ) current treatment immunosuppressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>